BclXL (Bcl2l1) gene therapy lessens retinal ganglion cell soma loss but not axonal degeneration after acute axonal injury.

Autor:	Marola, Olivia J., Yablonski, Sarah E. R., Shrager, Peter G., Nickells, Robert W., Libby, Richard T.
Zdroj:	Cell Death Discovery; 7/22/2022, Vol. 8 Issue 1, p1-4, 4p
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Full text from SpringerLink